N/A
N=817
Evaluation of the Implementation and Effectiveness of IPP-HPV
HPV Vaccination
Bottom Line
View on ClinicalTrials.gov: NCT02994290 ↗Enrolled (actual)
817
Serious AEs
—
Results posted
Jan 2023
Primary outcome: Primary: Count of Eligible Patients Agreeing to Receive a Dose of Vaccine — 686; 101 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- HPV vaccine (Drug); Inpatient Postpartum HPV Immunization Quality Improvement Program (Behavioral)
- Age
- Pediatric, Adult · 15+ yrs
- Sex
- Female
- Sponsor
- Yale University
- Primary completion
- Oct 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Count of Eligible Patients Agreeing to Receive a Dose of Vaccine |
686; 101 | — |
| PRIMARY HPV Vaccine Receptivity Thematic Interview |
5; 5 | — |
| PRIMARY Barriers to Receiving the HPV Vaccine Thematic Interview |
5; 5 | — |
| SECONDARY Number of Participants Who Received or Did Not Receive a Dose of Vaccine |
491; 296 | — |
| SECONDARY Receptivity of Healthcare Providers Thematic Interviews |
5 | — |
| SECONDARY Concerns of Healthcare Providers Thematic Interview |
2 | — |
Summary
The purpose of the proposed pilot study is to assess the implementation of IPP-HPV immunization at Yale New Haven Hospital (YNHH) and to identify potential barriers to and facilitators of this intervention to optimize its feasibility and effectiveness. It is imperative that innovative interventions be developed to achieve comprehensive utilization of this highly effective vaccine to reduce rates of HPV infection, lower rates of cervical and other HPV associated cancers, and address cancer disparities.
Eligibility Criteria
Inclusion Criteria
- Women participating in the IPP-HPV Quality Improvement Program:
- Postpartum YNHH Women's Center and CWHM patients
- ≤ 26 years at time of delivery who deliver at YNHH YSC or SRC
- Have not already received 3 doses of the HPV vaccine at time of delivery
- Fluent in English or Spanish
- Able and willing to provide consent
AND
- Yale New Haven Hospital (YNHH) Women's Center and Center for Women's Health and Midwifery (CWHM) postpartum patients
- ≤ 26 years of age
- Delivered at YNHH York Street Campus (YSC) or Saint Raphael Campus (SRC) in the first year of the IPP-HPV program or in the one year preceding implementation of the program
OR
- YNHH inpatient postpartum nurses or Women's Center outpatient postpartum nurses or inpatient or outpatient obstetric providers affiliated with the Women's Center or Center for Women's Health and Midwifery
- Able and willing to provide consent
Exclusion Criteria
-
Data sourced from ClinicalTrials.gov (NCT02994290). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.